Patients with an implanted cardioverter defibrillator: a new challenge

Area of Science:

• Cardiology
• Biomedical Engineering

Background:

• The automatic implantable cardioverter-defibrillator (AICD) is a critical device for managing life-threatening tachydysrhythmias.
• Since its 1985 approval, the AICD has been implanted in nearly 12,000 patients, establishing it as a "gold standard" therapy.

Purpose of the Study:

• To highlight the significance of the AICD in managing tachydysrhythmias.
• To discuss the evolving technology and future advancements in AICD devices.
• To emphasize the importance of emergency nurse preparedness for AICD patients.

Main Methods:

• Review of AICD device history and implantation statistics.
• Analysis of current and investigational AICD technological advancements.
• Discussion of clinical implications for emergency nursing.

Main Results:

• The AICD is widely adopted and considered the standard of care for tachydysrhythmia management.
• Future AICD versions, like the investigational VENTAKP, will offer enhanced programmability (shock energy, delay features for VT).
• Increasing use is anticipated for patients at risk of sudden cardiac death.

Conclusions:

• The AICD represents a significant advancement in cardiac rhythm management.
• Ongoing technological innovation promises improved patient outcomes and expanded therapeutic applications.
• Emergency nurses require specific knowledge to effectively manage patients with AICDs.